Use of antibiotics in infancy and childhood and risk of recurrent abdominal pain—a Swedish birth cohort study

The etiology of recurrent abdominal pain of functional origin (AP) is largely unknown. Antibiotic treatment influences the intestinal microbiota, and a few studies have indicated an increased risk of AP in adults after antibiotic treatment. Corresponding data in children are lacking. The aim of this study was to explore the association between antibiotic treatment during childhood and AP at 12 years.

[1]  T. Dinan,et al.  Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .

[2]  C. Lam,et al.  An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome , 2012, Journal of neurogastroenterology and motility.

[3]  E. Zoetendal,et al.  Intestinal microbiota in functional bowel disorders: a Rome foundation report , 2012, Gut.

[4]  James Versalovic,et al.  The Human Microbiome and Its Potential Importance to Pediatrics , 2012, Pediatrics.

[5]  N. Nielsen,et al.  Cesarean section and offspring's risk of inflammatory bowel disease: A national cohort study , 2012, Inflammatory bowel diseases.

[6]  Armando Villarreal,et al.  Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. , 2012, WMJ : official publication of the State Medical Society of Wisconsin.

[7]  B. Wettermark,et al.  Antibiotics and asthma medication in a large register‐based cohort study – confounding, cause and effect , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  Aleksandar Milosavljevic,et al.  Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. , 2011, Gastroenterology.

[9]  G. Barlow,et al.  Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects , 2011, Digestive Diseases and Sciences.

[10]  T. Dinan,et al.  Altered peripheral toll‐like receptor responses in the irritable bowel syndrome , 2011, Alimentary pharmacology & therapeutics.

[11]  Henry C. Lin,et al.  Double-blind, Placebo-controlled Antibiotic Treatment Study of Small Intestinal Bacterial Overgrowth in Children With Chronic Abdominal Pain , 2011, Journal of pediatric gastroenterology and nutrition.

[12]  S. Rajindrajith,et al.  Prevalence of functional gastrointestinal diseases in a cohort of Sri Lankan adolescents: comparison between Rome II and Rome III criteria. , 2011, Journal of tropical pediatrics.

[13]  A. Fanning,et al.  Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome , 2011, The American Journal of Gastroenterology.

[14]  H. Forssberg,et al.  Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.

[15]  W. Chey,et al.  Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.

[16]  A. Griffiths,et al.  Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends , 2011, Inflammatory bowel diseases.

[17]  Cecilia Jernberg,et al.  Long-term impacts of antibiotic exposure on the human intestinal microbiota. , 2010, Microbiology.

[18]  M. Saps,et al.  A Million-dollar Work-up for Abdominal Pain: Is It Worth It? , 2010, Journal of pediatric gastroenterology and nutrition.

[19]  M. Wickman,et al.  Breast-feeding in relation to asthma, lung function, and sensitization in young schoolchildren. , 2010, The Journal of allergy and clinical immunology.

[20]  Michael D Cabana,et al.  Role of the gut microbiota in defining human health , 2010, Expert review of anti-infective therapy.

[21]  A. Garg,et al.  An Outbreak of Acute Bacterial Gastroenteritis Is Associated With an Increased Incidence of Irritable Bowel Syndrome in Children , 2010 .

[22]  Anders F. Andersson,et al.  Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome , 2010, PloS one.

[23]  L. Öhman,et al.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions , 2010, Nature Reviews Gastroenterology &Hepatology.

[24]  T. Markestad,et al.  Diagnosing Pediatric Functional Abdominal Pain in Children (4–15 Years Old) According to the Rome III Criteria: Results From a Norwegian Prospective Study , 2009, Journal of pediatric gastroenterology and nutrition.

[25]  A. Craxì,et al.  Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. , 2009, World journal of gastroenterology.

[26]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[27]  C. Di Lorenzo,et al.  A prospective school-based study of abdominal pain and other common somatic complaints in children. , 2009, The Journal of pediatrics.

[28]  S. Salminen,et al.  Mode of Delivery – Effects on Gut Microbiota and Humoral Immunity , 2007, Neonatology.

[29]  Anders Sundström,et al.  The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.

[30]  H. Goossens,et al.  Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  S. Murch,et al.  Could peripartum antibiotics have delayed health consequences for the infant? , 2006, BJOG : an international journal of obstetrics and gynaecology.

[32]  C. Di Lorenzo,et al.  Childhood Functional Gastrointestinal Disorders : Child / Adolescent , 2022 .

[33]  M. Simrén,et al.  A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  N. Talley,et al.  The Epidemiology of Childhood Recurrent Abdominal Pain in Western Countries: A Systematic Review , 2005, The American Journal of Gastroenterology.

[35]  Marian Rewers,et al.  Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? , 2005, Gastroenterology.

[36]  J. Jansson,et al.  Monitoring of Antibiotic-Induced Alterations in the Human Intestinal Microflora and Detection of Probiotic Strains by Use of Terminal Restriction Fragment Length Polymorphism , 2005, Applied and Environmental Microbiology.

[37]  M Svartengren,et al.  Strategies for preventing wheezing and asthma in small children , 2003, Allergy.

[38]  M. Wickman,et al.  The BAMSE Project: presentation of a prospective longitudinal birth cohort study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[39]  M. Mendall,et al.  Antibiotics increase functional abdominal symptoms , 2002, American Journal of Gastroenterology.

[40]  C E Nord,et al.  Effect of antimicrobial agents on the ecological balance of human microflora. , 2001, The Lancet. Infectious diseases.

[41]  M. Mendall,et al.  Antibiotic use, childhood affluence and irritable bowel syndrome (IBS) , 1998, European journal of gastroenterology & hepatology.

[42]  T. King.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea. , 1996, Clinical nutrition.

[43]  C. Nord.  The effect of antimicrobial agents on the ecology of the human intestinal microflora. , 1993, Veterinary microbiology.

[44]  J APLEY,et al.  Recurrent Abdominal Pains: A Field Survey of 1,000 School Children , 1958, Archives of disease in childhood.

[45]  J. Ludvigsson,et al.  Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. , 2012, Gastroenterology.

[46]  J. Barkin.  The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial , 2007 .